Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-09-07 | Martyn D. Greenacre was appointed to our Board of Directors on December 8, 2011 and serves on the Audit Committee. ... The Board of Directors has concluded that Mr. Greenacre should continue serving as a director based on his diversified board and management experience, particularly in the biotechnology field. ... Mr. Greenacre joined the Board on December 8, 2011. Mr. Greenacre's compensation as a Board member commenced under the 2012 Board of Directors Compensation Plan. |
| 2013-08-30 | Martyn D. Greenacre was appointed to our Board of Directors on December 8, 2011 and serves on the Audit Committee and Nominating and Governance Committee... The following table sets forth director compensation for 2012 showing total compensation of $92,400. |
| 2014-08-29 | Martyn D. Greenacre was appointed to our Board of Directors on December 8, 2011 and serves on the Audit Committee and Nominating and Governance Committee. |
| 2015-06-08 | At December 31, 2014, Mr. Greenacre had warrants to purchase 25,000 shares of our common stock, all of which were vested. At December 31, 2014, Mr. Greenacre had a total of 64,531 shares in stock awards outstanding, all of which were vested. The following table sets forth information on all compensation to NeoStem's directors (other than as reflected in the Summary Compensation Table) for the year ended December 31, 2014. Martyn Greenacre (6) 2014 $40,000 $108,780 — $148,780 |
Data sourced from SEC filings. Last updated: 2025-08-30